Ionis Delivers Positive Late-Stage Results for Two Partnered DrugsZacks Investment Research • 09/23/26
Polaris Rx Named Exclusive U.S. Distributor of AstraZeneca's FluMist® Home Service for Second Consecutive YearBusiness Wire • 09/23/26
European drugmakers call for faster trials, more spending to compete with US, ChinaReuters • 09/22/26
Astrazeneca (AZN) Ascends But Remains Behind Market: Some Facts to NoteZacks Investment Research • 09/21/26
AZN's Klygefa Gets CHMP Nod for Generalised Myasthenia Gravis in EUZacks Investment Research • 09/21/26
FDA Grants Priority Review to AZN's Filing for Rare Bone Disease DrugZacks Investment Research • 09/18/26
Is It Worth Investing in Astrazeneca (AZN) Based on Wall Street's Bullish Views?Zacks Investment Research • 09/16/26
AZN's Etcamah Fails Late-Stage Study for First-line Breast CancerZacks Investment Research • 09/14/26
Susan G. Komen® and AstraZeneca Partnership to Make Patient Navigation Available to AllBusiness Wire • 09/14/26